From: Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
Variables | <1 year (age in months) | ≥1 year (age in years) | General [mean(±SD)] |
---|---|---|---|
Age | 0.72 (±0.52) | 14.0 (±10) | 4.3 (±0.5) |
Gender (male/female) | 281/161 | 343/298 | 624/459 |
Weight (kg) | 11.6 (±7.0) | 49.4 (±35.8) | 61.0 (±42.8) |
Hospital stay (days) | 11 (+19) | 8 (+12) | 9 (+14) |
Diagnostic Group | |||
-Respiratory | 272 | 185 | 457 |
-Neurology | 42 | 119 | 161 |
-Blood and Hematopoietic | 67 | 75 | 142 |
-Gastrointestinal | 46 | 86 | 132 |
-Genito-urinary | 27 | 105 | 132 |
-Infectious Disease | 62 | 39 | 101 |
-Development and Nutrition | 36 | 24 | 60 |
-Surgery | 17 | 39 | 56 |
-Legal-Medical | 19 | 18 | 37 |
-Dermatology | 7 | 29 | 36 |
-Soft tissues | 7 | 29 | 36 |
-Metabolic | 12 | 20 | 32 |
-Genetic | 18 | 14 | 32 |
-Head and neck | 12 | 16 | 28 |
-Trauma and Orthopedics | 7 | 16 | 23 |
-Cardiovascular | 6 | 10 | 16 |
-Autoimmune | / | 18 | 18 |
-Oncology | / | 14 | 14 |
-Toxicology | / | 3 | 3 |
-Obstetrics and Gynecology | 1 | / | 1 |